Standardization of D2 Lymphadenectomy and Surgical Quality Control: KLASS-02-QC

Sponsor
Yonsei University (Other)
Overall Status
Unknown status
CT.gov ID
NCT01283893
Collaborator
(none)
160
1
32
5

Study Details

Study Description

Brief Summary

Gastric cancer is one of the most common cancers in Korea. Having achieved excellent long-term survival for early gastric cancer patients, there is a growing interest in improving the quality of life of these patients without compromising their prognosis. Laparoscopic surgery for early gastric cancer have been found to be safe and feasible with superior short-term outcomes. Although laparoscopic gastrectomy with D2 lymphadenectomy is being performed for patients with locally advanced gastric cancer; the completeness of the D2 lymphadenectomy during laparoscopic surgery has not been evaluate and no standardized procedure exists. To conduct a clinical trial comparing laparoscopic D2 lymphadenectomy to the open approach, quality control of D2 lymphadenectomy procedure is necessary.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Laparoscopic distal gastrectomy with D2 lymphadenectomy

Study Design

Study Type:
Observational
Anticipated Enrollment :
160 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Standardization of D2 Lymphadenectomy and Surgical Quality Control for KLASS-02 Trial: KLASS-02-QC
Study Start Date :
Dec 1, 2010
Anticipated Primary Completion Date :
Aug 1, 2013
Anticipated Study Completion Date :
Aug 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Laparoscopy group

Laparoscopy group: patients who underwent laparoscopic distal gastrectomy with D2 lymphadenectomy

Procedure: Laparoscopic distal gastrectomy with D2 lymphadenectomy
The commonly practice laparoscopic surgery for gastric cancer involves a partial omentectomy+D1+b lymphadenectomy which includes the dissection of Lymph node stations 1, 3, 4, 5, 6, 7, 8a, 9; however, when performing a D2 lymph node dissection, a total omentectomy plus LN1, 3, 4, 5, 6, 7, 8a, 9, 12a retrieval will be completed. The same total omentectomy+D2 lymphadenectomy will also be performed by the open method.

Open group

Open group: patients who underwent open distal gastrectomy with D2 lymphadenectomy

Procedure: Laparoscopic distal gastrectomy with D2 lymphadenectomy
The commonly practice laparoscopic surgery for gastric cancer involves a partial omentectomy+D1+b lymphadenectomy which includes the dissection of Lymph node stations 1, 3, 4, 5, 6, 7, 8a, 9; however, when performing a D2 lymph node dissection, a total omentectomy plus LN1, 3, 4, 5, 6, 7, 8a, 9, 12a retrieval will be completed. The same total omentectomy+D2 lymphadenectomy will also be performed by the open method.

Outcome Measures

Primary Outcome Measures

  1. Evaluation of operative procedure according to predetermined criteria [6 months]

    Video recording during the operation Peer reviewer's evaluation according to predetermined criteria Final approval by review committee Predetermined criteria: exact dissection of lymph node (LN) station satisfying each requirements (omentum, LN1, LN3, LN4sb, LN4d, LN5, LN6, LN7, LN8a, LN9, LN11p and LN12a)

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients must have documented diagnosis of gastric cancer

  • Patients receiving laparoscopic gastric cancer surgery without preoperative evidence of serosal invasion and distant lymph node metastasis as determined by evaluation of preoperative CT-scan, upper endoscopy, or endoscopic ultrasound.

  • Patients undergoing gastric cancer surgery without plans for combined operations, such as resection of another organ for another primary disease.

  • Patients who have received comprehensive explanation about the planned study, understand and accept all the terms of the study and willingly give consent to participate in all the required elements of the study

Exclusion Criteria:
  • Patients without mental competence

  • Patients who are illiterate

  • Patients who are pregnant

  • Patients < 20 and > 80 years old

Contacts and Locations

Locations

Site City State Country Postal Code
1 Severance Hospital Seoul Korea, Republic of 120-752

Sponsors and Collaborators

  • Yonsei University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Yonsei University
ClinicalTrials.gov Identifier:
NCT01283893
Other Study ID Numbers:
  • 4-2010-0637
First Posted:
Jan 26, 2011
Last Update Posted:
Jun 4, 2013
Last Verified:
Jun 1, 2013
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 4, 2013